If you are leasing a car, what’s the point of paying thousands of dollars due at lease signing? My contract says tax, title, fees and licensing — but then wouldn’t I have to pay that again at the end ...

Thread is a protocol designed to connect smart home devices in a wireless mesh network. It works much like Wi-Fi but requires less power. With Thread, devices from any manufacturer can create a ...

Shifting Gears season 2 ended with a love triangle cliffhanger — but there’s already plans for more “bombshell” reveals in season 3. “The long term plan from when I started the show — even in casting ...

Ricursive Intelligence, founded by two former Google researchers and valued at $4 billion, is among several efforts to automate the creation of artificial intelligence. Anna Goldie and Azalia ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Cory Benfield discusses the evolution of ...

AI-generated summary reviewed by our newsroom. Read our AI Policy. Macy’s will close its Triangle Town Center store, leaving two Triangle locations. Company cites focus on investing in stores and ...

Click to share on Facebook (Opens in new window) Facebook Click to share on X (Opens in new window) X Joe and Victoria originally formed a connection when he joined halfway through season 10 and as ...

Examining the tragic case involving Jennair Gerardot and Meredith Chapman, and how a complex relationship led to devastating consequences. What warning signs are often missed in such situations? Man ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...